John is a chemist with over 40 years’ experience in Pharmaceutical Development gained with a number of major pharmaceutical companies.

He obtained his BSc from Bristol University and his PhD (part-time) from University of Nottingham School of Pharmacy. Until November 2010 he was a Vice President in GlaxoSmithKline and ran various multi-national departments involved with analytical chemistry, Product Line Extension development, physical properties and developability and early stage CMC support. He has a good knowledge of Quality by Design, Change Control and Technology Transfer. He is currently CEO of John Wahlich Associates Ltd a consulting company specialising in the pharmaceutical sciences.

John is currently consulting for a number of companies on early stage product development. He is an Advisory Board member of the UK Academy of Pharmaceutical Sciences (APS), has co-hosted successful workshops on drug developability and has co-organised a number of APS International Pharm Sci conferences (the UK’s premier Pharm Sci event).